Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI North America CPhI North America
Not Confirmed
Not Confirmed
20-22 May, 2025
World Vaccine Conferen...World Vaccine Conference
Not Confirmed
Not Confirmed
22-24 April, 2025
Not Confirmed
Not Confirmed
22-25 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI North America CPhI North America
Industry Trade Show
Not Confirmed
20-22 May, 2025
World Vaccine Conferen...World Vaccine Conference
Industry Trade Show
Not Confirmed
22-24 April, 2025
Industry Trade Show
Not Confirmed
22-25 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/how-trump-s-tariffs-on-imported-drugs-can-hurt-supply-chains-consumers-and-industry
03 Apr 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/japans-marubeni-takes-sumitomos-asia-pharma-business-make-new-company-deal-worth-300m
21 Jan 2025
// BIOSPECTRUM
https://www.biospectrumasia.com/news/25/25470/sumitomo-to-market-johnson-johnsons-schizophrenia-drug-in-japan.html
04 Dec 2024
// FIERCE PHARMA
https://www.fiercepharma.com/marketing/sumitomo-brings-together-gemtesa-go-getters-discuss-overactive-bladder-symptoms
08 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/joint-venture-company-established-for-incubation-of-early-drug-discovery-programs-investment-from-takeda-astellas-and-sumitomo-mitsui-banking-302270829.html#:~:text=In%2DLanguage%20News-,Joint%20Venture%20Company%20Established%20for%20Incubation%20of%20Early%20Drug%20Discovery,Astellas%20and%20Sumitomo%20Mitsui%20Banking&text=Ciconia%20Bioventures%20Inc.
02 May 2024
// PHARMA JAPAN
02 Apr 2024
// BUSINESSWIRE
ABOUT THIS PAGE
Sumitomo is a supplier offers 4 products (APIs, Excipients or Intermediates).
Find a price of Droxidopa bulk offered by Sumitomo
Find a price of Lurasidone Hydrochloride bulk offered by Sumitomo
Find a price of Meropenem bulk offered by Sumitomo
Find a price of Zonisamide bulk offered by Sumitomo